Viewing Study NCT03036904

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-25 @ 6:42 PM
Study NCT ID: NCT03036904
Status: COMPLETED
Last Update Posted: 2022-08-24
First Post: 2017-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
Sponsor: Weill Medical College of Cornell University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-Cell Lymphoma View
None High Grade B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None venetoclax View
None dose-adjusted EPOCH-R View
None aggressive B-Cell lymphoma View
None Lymphoma View
None Non-Hodgkin lymphoma View
None Diffuse large B-cell lymphoma View
None Double hit lymphoma View